Column Group Opportunity III, LP, 10% Owner at Eikon Therapeutics, Inc. (EIKN), bought 2,806,043 shares at $18.00 ($38.1M) on 2026-02-06, disclosed to the SEC on 2026-02-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 688,283 | $0 | 0.0% |
| 2 | $18.00 | 49,556 | $892K | 2.3% |
| 3 | $18.00 | 630,881 | $11.4M | 29.8% |
| 4 | $18.00 | 1,437,323 | $25.9M | 67.9% |
| Total | $13.58 avg | 2,806,043 | $38.1M | 100% |
| Filing → |